NasdaqGS:HCATHealthcare Services
Health Catalyst (HCAT) Losses Swell To US$178 Million Challenging Margin Improvement Narrative
Health Catalyst (HCAT) just wrapped up FY 2025 with Q4 total revenue of US$74.7 million and a basic EPS loss of US$1.28, alongside a full year trailing twelve month revenue base of US$311.1 million and a net loss of US$178.0 million. Over recent quarters the company has seen quarterly revenue move from US$79.4 million in Q1 2025 to US$80.7 million in Q2, US$76.3 million in Q3 and US$74.7 million in Q4. Basic EPS losses ranged from US$0.35 to US$1.28 per share, underscoring a business that is...